0.0118
+0.0007
+(6.31%)
At close: January 8 at 3:00:00 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
3,802.1320
4,435.6880
4,997.3740
4,603.6030
Operating Income
-3,802.1320
-4,435.6880
-4,997.3740
-4,603.6030
Net Non Operating Interest Income Expense
-1,373.4950
-1,170.3190
-176.6720
-34.5160
Other Income Expense
--
1.1140
-166.3080
-32.1360
Pretax Income
-5,174.5130
-5,604.8930
-5,340.3540
-4,670.2550
Net Income Common Stockholders
-5,174.5130
-5,604.8930
-5,340.3540
-4,670.2550
Diluted NI Available to Com Stockholders
-5,174.5130
-5,604.8930
-5,340.3540
-4,670.2550
Basic EPS
-0.01
-0.01
-0.01
-1.37
Diluted EPS
-0.01
-0.01
-0.01
-1.37
Basic Average Shares
--
572,009.9110
3,374.9450
3,402.1570
Diluted Average Shares
--
572,009.9110
322,800.3270
3,402.1570
Total Operating Income as Reported
-3,805.9320
-4,439.4880
-5,014.3320
-4,635.7390
Total Expenses
3,802.1320
4,435.6880
4,997.3740
4,603.6030
Net Income from Continuing & Discontinued Operation
-5,174.5130
-5,604.8930
-5,340.3540
-4,670.2550
Normalized Income
-5,170.7130
-5,601.0930
-5,174.0460
-4,638.1190
Interest Expense
1,373.4950
1,170.3190
176.6720
34.5160
Net Interest Income
-1,373.4950
-1,170.3190
-176.6720
-34.5160
EBIT
-3,801.0180
-4,434.5740
-5,163.6820
-4,635.7390
EBITDA
-3,793.0620
-4,426.6180
-5,156.9380
-4,630.4380
Reconciled Depreciation
7.9560
7.9560
6.7440
5.3010
Net Income from Continuing Operation Net Minority Interest
-5,174.5130
-5,604.8930
-5,340.3540
-4,670.2550
Total Unusual Items Excluding Goodwill
-3.8000
-3.8000
-166.3080
-32.1360
Total Unusual Items
-3.8000
-3.8000
-166.3080
-32.1360
Normalized EBITDA
-3,789.2620
-4,422.8180
-4,990.6300
-4,598.3020
12/31/2020 - 3/30/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNB0.F Fortress Biotech, Inc.
6.45
+1.57%
IMTXW Immatics N.V.
0.0900
-43.75%
WSNAF Wesana Health Holdings Inc.
0.0027
0.00%
DRMAW Dermata Therapeutics, Inc.
0.0149
+34.23%
SRZNW Surrozen, Inc.
0.0500
0.00%
TYPTF
0.0280
0.00%
KTTAW Pasithea Therapeutics Corp.
0.0251
0.00%
KRBP Kiromic BioPharma, Inc.
0.9250
0.00%
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
REVBW Revelation Biosciences, Inc.
0.0140
+7.69%